Noriyuki Enomoto Selected Research

Thrombocytopenia (Thrombopenia)

1/2019	Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study.
1/2016	Continuation maintenance therapy with S-1 in chemotherapy-naïve patients with advanced squamous cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noriyuki Enomoto Research Topics

Disease

31	Idiopathic Pulmonary Fibrosis 02/2024 - 07/2005
24	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2024 - 11/2004
19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 12/2015
15	Neoplasms (Cancer) 04/2024 - 09/2017
13	Disease Progression 02/2024 - 01/2015
12	Asthma (Bronchial Asthma) 01/2023 - 03/2003
9	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2016
9	Dermatomyositis (Dermatopolymyositis) 12/2023 - 01/2015
9	Inflammation (Inflammations) 01/2023 - 02/2012
9	Infections 11/2022 - 01/2005
9	Chronic Obstructive Pulmonary Disease (COPD) 05/2022 - 01/2015
8	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 02/2005
7	Pneumonia (Pneumonitis) 01/2023 - 04/2004
7	Idiopathic Interstitial Pneumonias 01/2021 - 11/2004
6	Adenocarcinoma of Lung 01/2022 - 01/2017
5	Sarcoidosis (Schaumann Disease) 07/2022 - 01/2005
5	Fibrosis (Cirrhosis) 01/2021 - 07/2005
5	Nausea 01/2019 - 12/2015
5	Vascular Diseases (Vascular Disease) 01/2016 - 11/2004
4	COVID-19 12/2023 - 01/2022
4	Rheumatoid Arthritis 01/2023 - 09/2008
4	Dyspnea (Shortness of Breath) 01/2019 - 11/2004
4	Vomiting 01/2019 - 12/2015
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2024 - 01/2018
3	Death (Near-Death Experience) 04/2022 - 11/2020
3	Connective Tissue Diseases (Connective Tissue Disease) 01/2022 - 10/2010
3	Pneumothorax 01/2021 - 01/2020
3	Bronchiectasis 01/2018 - 11/2004
3	Cough 04/2016 - 12/2006
2	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 11/2016
2	Amyopathic dermatomyositis 11/2022 - 08/2018
2	Body Weight (Weight, Body) 02/2022 - 12/2021
2	Cryptogenic Organizing Pneumonia 01/2022 - 02/2005
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2022 - 06/2015
2	Obesity 01/2022 - 01/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2021
2	Neutropenia 01/2021 - 01/2019
2	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2016

Drug/Important Bio-Agent (IBA)

11	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 03/2003
8	CollagenIBA 02/2024 - 11/2004
8	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 07/2005
8	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 12/2015
7	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2019
7	Biomarkers (Surrogate Marker)IBA 11/2021 - 09/2014
6	Proteins (Proteins, Gene)FDA Link 02/2024 - 11/2015
6	CytokinesIBA 12/2023 - 02/2012
6	ErbB Receptors (EGF Receptor)IBA 11/2022 - 01/2017
6	AutoantibodiesIBA 01/2022 - 01/2006
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 04/2012
5	AntibodiesIBA 02/2024 - 09/2008
5	SteroidsIBA 02/2024 - 11/2004
5	Oxygen (Dioxygen)IBA 01/2023 - 03/2017
5	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2016
4	Bleomycin (Blenoxane)FDA LinkGeneric 02/2024 - 01/2018
4	NivolumabIBA 02/2022 - 01/2019
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2015
4	pirfenidoneIBA 07/2021 - 01/2014
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 05/2008
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2017
4	Mannose ReceptorIBA 02/2020 - 01/2018
4	AntiemeticsIBA 01/2019 - 12/2015
4	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019 - 01/2015
4	Therapeutic UsesIBA 01/2015 - 05/2008
3	VaccinesIBA 12/2023 - 10/2009
3	Tyrosine Kinase InhibitorsIBA 11/2022 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2021 - 11/2004
3	Peroxidase (Myeloperoxidase)IBA 01/2021 - 05/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 11/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 11/2004
3	Phenobarbital (Luminal)FDA Link 01/2019 - 12/2018
3	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 09/2013
3	Interleukin-17 (Interleukin 17)IBA 10/2018 - 01/2014
3	Polymyxin B (Aerosporin)FDA LinkGeneric 02/2015 - 05/2008
2	indium-bleomycinIBA 02/2024 - 08/2022
2	Docetaxel (Taxotere)FDA Link 01/2024 - 06/2018
2	atezolizumabIBA 07/2023 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2023 - 08/2018
2	AllergensIBA 01/2023 - 02/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 07/2022 - 01/2022
2	Bronchodilator Agents (Bronchodilators)IBA 05/2022 - 01/2015
2	LigandsIBA 02/2022 - 01/2020
2	Serum AlbuminIBA 02/2022 - 12/2021
2	LipidsIBA 01/2022 - 01/2005
2	PlatinumIBA 12/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 06/2018
2	EnzymesIBA 01/2021 - 09/2008
2	ImmunosorbentsIBA 01/2021 - 09/2008
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 01/2015
2	Angiopoietin-1IBA 01/2021 - 01/2016
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 11/2020 - 10/2010
2	Methylprednisolone FDA LinkGeneric 01/2020 - 07/2005
2	cyclic citrullinated peptideIBA 07/2019 - 09/2008
2	Budesonide (Pulmicort)FDA LinkGeneric 01/2019 - 10/2016
2	Formoterol Fumarate (Oxis)FDA Link 01/2019 - 10/2016

Therapy/Procedure

48	Therapeutics 02/2024 - 03/2003
11	Drug Therapy (Chemotherapy) 01/2022 - 12/2015
3	Artificial Respiration (Mechanical Ventilation) 04/2022 - 02/2005
2	Cannula 11/2022 - 01/2020
2	Aftercare (After-Treatment) 01/2022 - 06/2015
2	Palliative Care (Palliative Therapy) 01/2021 - 11/2020